

The global market for Bio-Layer Interferometry (BLI) Systems was valued at US$ 382 million in the year 2024 and is projected to reach a revised size of US$ 645 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Bio-Layer Interferometry (BLI) Systems are advanced optical biosensing instruments that operate based on the principle of detecting changes in the interference pattern of light reflected from a biosensor tip as biomolecular interactions, such as protein-protein, protein-small molecule, or antibody-antigen interactions, take place on its surface. They offer real-time, label-free analysis capabilities, enabling precise quantification of binding kinetics and affinity, and are widely utilized in diverse fields like drug discovery, antibody engineering, and biomedical research.
Bio-Layer Interferometry (BLI) systems are gaining significant traction in the life sciences, especially for applications related to biomolecular interaction analysis and biosensor technologies. Here are some current market trends:
BLI is increasingly being used in the development of biologics and vaccines, as it allows for label-free and real-time monitoring of molecular interactions. It’s especially helpful in early-stage drug discovery to analyze binding affinities and kinetics.
Pharmaceutical companies are adopting BLI technologies to streamline the drug development process and reduce costs, which is driving market growth.
Manufacturers are focusing on enhancing the sensitivity, throughput, and usability of BLI systems. Developments such as multi-channel systems that can analyze several interactions simultaneously are gaining popularity.
Integration with other technologies, like microfluidics and artificial intelligence, is helping to make BLI systems more precise and adaptable to complex experimental setups.
Beyond research and development, BLI technology is being explored for clinical diagnostics, particularly in detecting biomarkers and monitoring therapeutic responses. This has widened the scope of BLI applications beyond research labs.
The growing emphasis on personalized medicine has fueled interest in BLI for analyzing specific patient responses at the molecular level.
The adoption of BLI technology by academic institutions and contract research organizations (CROs) is on the rise. Many of these organizations require advanced technologies for studying protein-protein interactions, which is where BLI is especially useful.
Government funding for life sciences research is also a key driver, encouraging the use of sophisticated platforms like BLI.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio-Layer Interferometry (BLI) Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Layer Interferometry (BLI) Systems.
The Bio-Layer Interferometry (BLI) Systems market size, estimations, and forecasts are provided in terms of output/shipments (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio-Layer Interferometry (BLI) Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-Layer Interferometry (BLI) Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sartorius (ForteBio)
Gator Bio
by Type
Low and Medium Throughput
High Throughput
by Application
Drug Discovery
Antibody Engineering
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bio-Layer Interferometry (BLI) Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bio-Layer Interferometry (BLI) Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bio-Layer Interferometry (BLI) Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Bio-Layer Interferometry (BLI) Systems Market Overview
1.1 Product Definition
1.2 Bio-Layer Interferometry (BLI) Systems by Type
1.2.1 Global Bio-Layer Interferometry (BLI) Systems Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Low and Medium Throughput
1.2.3 High Throughput
1.3 Bio-Layer Interferometry (BLI) Systems by Application
1.3.1 Global Bio-Layer Interferometry (BLI) Systems Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Antibody Engineering
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Bio-Layer Interferometry (BLI) Systems Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Bio-Layer Interferometry (BLI) Systems Production Estimates and Forecasts (2020-2031)
1.4.4 Global Bio-Layer Interferometry (BLI) Systems Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bio-Layer Interferometry (BLI) Systems Production Market Share by Manufacturers (2020-2025)
2.2 Global Bio-Layer Interferometry (BLI) Systems Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Bio-Layer Interferometry (BLI) Systems, Industry Ranking, 2023 VS 2024
2.4 Global Bio-Layer Interferometry (BLI) Systems Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Bio-Layer Interferometry (BLI) Systems Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Bio-Layer Interferometry (BLI) Systems, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bio-Layer Interferometry (BLI) Systems, Product Offered and Application
2.8 Global Key Manufacturers of Bio-Layer Interferometry (BLI) Systems, Date of Enter into This Industry
2.9 Bio-Layer Interferometry (BLI) Systems Market Competitive Situation and Trends
2.9.1 Bio-Layer Interferometry (BLI) Systems Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bio-Layer Interferometry (BLI) Systems Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bio-Layer Interferometry (BLI) Systems Production by Region
3.1 Global Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Bio-Layer Interferometry (BLI) Systems Production Value by Region (2020-2031)
3.2.1 Global Bio-Layer Interferometry (BLI) Systems Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Bio-Layer Interferometry (BLI) Systems by Region (2026-2031)
3.3 Global Bio-Layer Interferometry (BLI) Systems Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Bio-Layer Interferometry (BLI) Systems Production Volume by Region (2020-2031)
3.4.1 Global Bio-Layer Interferometry (BLI) Systems Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Bio-Layer Interferometry (BLI) Systems by Region (2026-2031)
3.5 Global Bio-Layer Interferometry (BLI) Systems Market Price Analysis by Region (2020-2025)
3.6 Global Bio-Layer Interferometry (BLI) Systems Production and Value, Year-over-Year Growth
3.6.1 North America Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Bio-Layer Interferometry (BLI) Systems Production Value Estimates and Forecasts (2020-2031)
4 Bio-Layer Interferometry (BLI) Systems Consumption by Region
4.1 Global Bio-Layer Interferometry (BLI) Systems Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Bio-Layer Interferometry (BLI) Systems Consumption by Region (2020-2031)
4.2.1 Global Bio-Layer Interferometry (BLI) Systems Consumption by Region (2020-2025)
4.2.2 Global Bio-Layer Interferometry (BLI) Systems Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Bio-Layer Interferometry (BLI) Systems Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Bio-Layer Interferometry (BLI) Systems Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bio-Layer Interferometry (BLI) Systems Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Bio-Layer Interferometry (BLI) Systems Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Bio-Layer Interferometry (BLI) Systems Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Bio-Layer Interferometry (BLI) Systems Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bio-Layer Interferometry (BLI) Systems Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Bio-Layer Interferometry (BLI) Systems Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Bio-Layer Interferometry (BLI) Systems Production by Type (2020-2031)
5.1.1 Global Bio-Layer Interferometry (BLI) Systems Production by Type (2020-2025)
5.1.2 Global Bio-Layer Interferometry (BLI) Systems Production by Type (2026-2031)
5.1.3 Global Bio-Layer Interferometry (BLI) Systems Production Market Share by Type (2020-2031)
5.2 Global Bio-Layer Interferometry (BLI) Systems Production Value by Type (2020-2031)
5.2.1 Global Bio-Layer Interferometry (BLI) Systems Production Value by Type (2020-2025)
5.2.2 Global Bio-Layer Interferometry (BLI) Systems Production Value by Type (2026-2031)
5.2.3 Global Bio-Layer Interferometry (BLI) Systems Production Value Market Share by Type (2020-2031)
5.3 Global Bio-Layer Interferometry (BLI) Systems Price by Type (2020-2031)
6 Segment by Application
6.1 Global Bio-Layer Interferometry (BLI) Systems Production by Application (2020-2031)
6.1.1 Global Bio-Layer Interferometry (BLI) Systems Production by Application (2020-2025)
6.1.2 Global Bio-Layer Interferometry (BLI) Systems Production by Application (2026-2031)
6.1.3 Global Bio-Layer Interferometry (BLI) Systems Production Market Share by Application (2020-2031)
6.2 Global Bio-Layer Interferometry (BLI) Systems Production Value by Application (2020-2031)
6.2.1 Global Bio-Layer Interferometry (BLI) Systems Production Value by Application (2020-2025)
6.2.2 Global Bio-Layer Interferometry (BLI) Systems Production Value by Application (2026-2031)
6.2.3 Global Bio-Layer Interferometry (BLI) Systems Production Value Market Share by Application (2020-2031)
6.3 Global Bio-Layer Interferometry (BLI) Systems Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Sartorius (ForteBio)
7.1.1 Sartorius (ForteBio) Bio-Layer Interferometry (BLI) Systems Company Information
7.1.2 Sartorius (ForteBio) Bio-Layer Interferometry (BLI) Systems Product Portfolio
7.1.3 Sartorius (ForteBio) Bio-Layer Interferometry (BLI) Systems Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Sartorius (ForteBio) Main Business and Markets Served
7.1.5 Sartorius (ForteBio) Recent Developments/Updates
7.2 Gator Bio
7.2.1 Gator Bio Bio-Layer Interferometry (BLI) Systems Company Information
7.2.2 Gator Bio Bio-Layer Interferometry (BLI) Systems Product Portfolio
7.2.3 Gator Bio Bio-Layer Interferometry (BLI) Systems Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Gator Bio Main Business and Markets Served
7.2.5 Gator Bio Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bio-Layer Interferometry (BLI) Systems Industry Chain Analysis
8.2 Bio-Layer Interferometry (BLI) Systems Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bio-Layer Interferometry (BLI) Systems Production Mode & Process Analysis
8.4 Bio-Layer Interferometry (BLI) Systems Sales and Marketing
8.4.1 Bio-Layer Interferometry (BLI) Systems Sales Channels
8.4.2 Bio-Layer Interferometry (BLI) Systems Distributors
8.5 Bio-Layer Interferometry (BLI) Systems Customer Analysis
9 Bio-Layer Interferometry (BLI) Systems Market Dynamics
9.1 Bio-Layer Interferometry (BLI) Systems Industry Trends
9.2 Bio-Layer Interferometry (BLI) Systems Market Drivers
9.3 Bio-Layer Interferometry (BLI) Systems Market Challenges
9.4 Bio-Layer Interferometry (BLI) Systems Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Sartorius (ForteBio)
Gator Bio
Ìý
Ìý
*If Applicable.